Your browser doesn't support javascript.
loading
A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety.
Hijiya, Nobuko; Maschan, Alexey; Rizzari, Carmelo; Shimada, Hiroyuki; Dufour, Carlo; Goto, Hiroaki; Kang, Hyoung Jin; Guinipero, Terri; Karakas, Zeynep; Bautista, Francisco; Ducassou, Stéphane; Yoo, Keon Hee; Zwaan, Christian Michel; Millot, Frédéric; Patterson, Briana; Samis, Jill; Aimone, Paola; Allepuz, Alex; Titorenko, Ksenia; Sosothikul, Darintr.
Afiliación
  • Hijiya N; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY.
  • Maschan A; Dmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Rizzari C; Department of Pediatrics, Pediatric Hematology Oncology Unit, University of Milano Bicocca, Monza Brianza per il Bambino e la sua Mamma (MBBM) Foundation, Azienda Socio Sanitaria Territoriale (ASST), Monza, Italy.
  • Shimada H; Keio University School of Medicine, Shinjuku-ku, Japan.
  • Dufour C; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Giannina Gaslini, Genoa, Italy.
  • Goto H; Kanagawa Children's Medical Center, Yokohama, Japan.
  • Kang HJ; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
  • Guinipero T; Wide River Institute of Immunology, Hongcheon-gun, South Korea.
  • Karakas Z; Nationwide Children's Hospital, The Ohio State University, Columbus, OH.
  • Bautista F; Department of Pediatric Hematology/Oncology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Ducassou S; Hospital Niño Jesus, Madrid, Spain.
  • Yoo KH; Groupe Hospitalier Pellegrin-Hôpital des Enfants, Bordeaux, France.
  • Zwaan CM; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Millot F; Department of Pediatric Oncology/Hematology, Erasmus Medical Center (MC)-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Patterson B; Innovative Therapies for Children with Cancer (ITCC) Consortium, The Netherlands.
  • Samis J; Unité d'Onco-Hématologie Pédiatrique, Centre d'Investigation Clinique (CIC) 1402 INSERM, Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France.
  • Aimone P; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA.
  • Allepuz A; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
  • Titorenko K; Novartis Pharma AG, Basel, Switzerland.
  • Sosothikul D; Novartis Pharma AG, Basel, Switzerland.
Blood Adv ; 5(14): 2925-2934, 2021 07 27.
Article en En | MEDLINE | ID: mdl-34309636
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Leucemia Mielógena Crónica BCR-ABL Positiva Límite: Child / Humans Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Leucemia Mielógena Crónica BCR-ABL Positiva Límite: Child / Humans Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article